<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03600311</url>
  </required_header>
  <id_info>
    <org_study_id>17933</org_study_id>
    <nct_id>NCT03600311</nct_id>
  </id_info>
  <brief_title>Resistance Exercise and Protein During Weight Loss</brief_title>
  <acronym>RIDE</acronym>
  <official_title>Using Resistance Exercise and Protein Consumption to Protect Bone Health During Weight Loss</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Nebraska Lincoln</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Nebraska Lincoln</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to determine if post-exercise protein supplementation can rescue
      the anabolic response of muscle and bone to resistance exercise during caloric restriction.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      1. Preliminary Testing Prior to the study start, participants will be weighed and body
           composition will be determined using bioimpedance analysis. Then participants will
           undergo a 5RM barbell back squat exercise testing procedure.

        2. Randomization

           Participants will proceed through each of the following conditions lasting 3 days:

           CON: Participants will be in energy balance and consume 1.2 g protein/kg BW/day.
           Participants will be provided 30 g maltodextrin post-exercise.

           CR+C: Participants will be restricted to 15 kcal/kg FFM/day and consume 1.2 g protein/kg
           BW/day. Participants will be provided 30 g maltodextrin post-exercise.

           CR+P: Participants will be restricted to 15 kcal/kg FFM/day and consume 1.2 g protein/kg
           BW/day. Participants will be provided 30 g whey protein post-exercise.

        3. Diet Prescription Dietary energy intake will be controlled using clinical products,
           maltodextrin and whey protein isolate to meet target energy intakes. Participants will
           receive calcium and Vitamin D supplementation throughout the study.

        4. Exercise Prescription Participants will perform one bout of 5 sets of 5 repetitions of
           barbell back squat exercise on the morning of Day 3 each condition. Additional exercise
           and intense physical activity will be prohibited.

        5. Assessments Body weight and composition (DXA + BIA), fasting blood draws for assessment
           of metabolic and anabolic hormones and questionnaires will be conducted before and after
           each condition. A 24-hour serial blood draw procedure will be conducted following each
           workout session on each Day 3.

        6. Washout Once a participant completes a study condition, participants will continue to
           take daily body weights at home for up to one week. Then participants will be required
           to wait one more week before completing their next condition during which they will
           resume regular diet and physical activity.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">August 31, 2018</start_date>
  <completion_date type="Actual">May 31, 2019</completion_date>
  <primary_completion_date type="Actual">May 1, 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change in Serum [IGF-1] (ng/mL)</measure>
    <time_frame>Baseline, Pre-Exercise, 0-24 Hours Post-Exercise</time_frame>
    <description>Measured via ELISA</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change in Serum [GH] (pg/mL)</measure>
    <time_frame>Baseline, Pre-Exercise, 0-24 Hours Post-Exercise</time_frame>
    <description>Measured via ELISA</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change in Serum [IGFBP-3] (ng/mL)</measure>
    <time_frame>Baseline, Pre-Exercise, 0-24 Hours Post-Exercise</time_frame>
    <description>Measured via ELISA</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change in Serum [P1NP] (pg/mL)</measure>
    <time_frame>Baseline, Pre-Exercise, 0-24 Hours Post-Exercise</time_frame>
    <description>Measured via ELISA</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change in Serum [CTX] (ng/mL)</measure>
    <time_frame>Baseline, Pre-Exercise, 0-24 Hours Post-Exercise</time_frame>
    <description>Measured via ELISA</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change in Serum [Sclerostin] (pmol/L)</measure>
    <time_frame>Baseline, Pre-Exercise, 0-24 Hours Post-Exercise</time_frame>
    <description>Measured via ELISA</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change in Body Weight (kg)</measure>
    <time_frame>Baseline and Day 4</time_frame>
    <description>Measured via Stadiometer</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in Body Fat Percentage (%)</measure>
    <time_frame>Baseline and Day 4</time_frame>
    <description>Measured via DXA and BIA</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in Perceived Hunger (mm or %)</measure>
    <time_frame>Baseline and Day 4</time_frame>
    <description>Measured on Visual Analog Scale within Survey</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">17</enrollment>
  <condition>Weight Loss</condition>
  <condition>Starvation</condition>
  <arm_group>
    <arm_group_label>Energy Balance</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Participants will be in energy balance and consume 1.2 g/kg BW protein. They will be provided 30 g of maltodextrin following exercise.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Caloric Restriction and CHO Supp</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Participants will be calorie restricted to 15 kcal/kg FFM/day and consume 1.2 g/kg BW protein. They will be provided 30 g of maltodextrin following exercise.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Caloric Restriction and PRO Supp</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Participants will be calorie restricted to 15 kcal/kg FFM/day and consume 1.2 g/kg BW protein. They will be provided 30 g of whey protein following exercise.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Caloric Restriction</intervention_name>
    <description>Participants will consume 15 kcal/kg FFM/day.</description>
    <arm_group_label>Caloric Restriction and CHO Supp</arm_group_label>
    <arm_group_label>Caloric Restriction and PRO Supp</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Post-Exercise Protein</intervention_name>
    <description>Participants will ingest 30 g of protein following exercise.</description>
    <arm_group_label>Caloric Restriction and PRO Supp</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Energy Balance</intervention_name>
    <description>Participants will consume 40 kcal/kg FFM/day.</description>
    <arm_group_label>Energy Balance</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Post-Exercise Carbohydrate</intervention_name>
    <description>Participants will ingest 30 g of carbohydrate following exercise.</description>
    <arm_group_label>Caloric Restriction and CHO Supp</arm_group_label>
    <arm_group_label>Energy Balance</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Calcium and Vitamin D</intervention_name>
    <description>Participants will be supplied Calcium and Vitamin D supplements throughout the study period matched to the CON condition.</description>
    <arm_group_label>Caloric Restriction and CHO Supp</arm_group_label>
    <arm_group_label>Caloric Restriction and PRO Supp</arm_group_label>
    <arm_group_label>Energy Balance</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Baseline Inclusion Criteria:

          -  Weigh at least 110 lbs

          -  Weight-Stable (2.5 kg) within the past six months

          -  Height-Stable (&lt; 0.25 inches) within the past year

          -  3 years of resistance training experience

        Tested Inclusion Criteria:

        - &lt;20% body fat (men) or &lt;30% body fat (women)

        Exclusion Criteria:

          -  Lactose intolerant

          -  Pregnancy

          -  Taking interfering medications such as steroids, thyroid or growth hormones
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>19 Years</minimum_age>
    <maximum_age>30 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Karsten Koehler</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Nebraska Lincoln</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Sports and Exercise Nutrition Laboratory, Department of Nutrition and Health Sciences, Ruth Leverton Hall</name>
      <address>
        <city>Lincoln</city>
        <state>Nebraska</state>
        <zip>68583</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>June 2019</verification_date>
  <study_first_submitted>July 9, 2018</study_first_submitted>
  <study_first_submitted_qc>July 24, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">July 26, 2018</study_first_posted>
  <last_update_submitted>June 10, 2019</last_update_submitted>
  <last_update_submitted_qc>June 10, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">June 12, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Starvation</mesh_term>
    <mesh_term>Body Weight</mesh_term>
    <mesh_term>Weight Loss</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Vitamin D</mesh_term>
    <mesh_term>Calcium</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

